Department of General Internal Medicine, Portland Veterans Affairs Medical Center, Mailcode RD71, 3710 SW US Veterans Hospital Rd, Portland, OR 97239, USA.
JAMA. 2011 Oct 19;306(15):1688-98. doi: 10.1001/jama.2011.1515.
Predicting hospital readmission risk is of great interest to identify which patients would benefit most from care transition interventions, as well as to risk-adjust readmission rates for the purposes of hospital comparison.
To summarize validated readmission risk prediction models, describe their performance, and assess suitability for clinical or administrative use.
The databases of MEDLINE, CINAHL, and the Cochrane Library were searched from inception through March 2011, the EMBASE database was searched through August 2011, and hand searches were performed of the retrieved reference lists. Dual review was conducted to identify studies published in the English language of prediction models tested with medical patients in both derivation and validation cohorts.
Data were extracted on the population, setting, sample size, follow-up interval, readmission rate, model discrimination and calibration, type of data used, and timing of data collection.
Of 7843 citations reviewed, 30 studies of 26 unique models met the inclusion criteria. The most common outcome used was 30-day readmission; only 1 model specifically addressed preventable readmissions. Fourteen models that relied on retrospective administrative data could be potentially used to risk-adjust readmission rates for hospital comparison; of these, 9 were tested in large US populations and had poor discriminative ability (c statistic range: 0.55-0.65). Seven models could potentially be used to identify high-risk patients for intervention early during a hospitalization (c statistic range: 0.56-0.72), and 5 could be used at hospital discharge (c statistic range: 0.68-0.83). Six studies compared different models in the same population and 2 of these found that functional and social variables improved model discrimination. Although most models incorporated variables for medical comorbidity and use of prior medical services, few examined variables associated with overall health and function, illness severity, or social determinants of health.
Most current readmission risk prediction models that were designed for either comparative or clinical purposes perform poorly. Although in certain settings such models may prove useful, efforts to improve their performance are needed as use becomes more widespread.
预测医院再入院风险对于确定哪些患者最受益于护理过渡干预以及为医院比较调整再入院率以进行风险调整非常重要。
总结已验证的再入院风险预测模型,描述其性能,并评估其在临床或管理中的适用性。
从 MEDLINE、CINAHL 和 Cochrane 图书馆的数据库中搜索了从成立到 2011 年 3 月的文献,从 2011 年 8 月起对 EMBASE 数据库进行了搜索,并对检索到的参考文献列表进行了手工搜索。双重审查用于确定以英语发表的研究,这些研究使用了在推导和验证队列中接受医疗患者测试的预测模型。
对人群、设置、样本量、随访间隔、再入院率、模型区分度和校准、使用的数据类型以及数据收集时间进行了数据提取。
在审查的 7843 条引文中有 30 项研究符合 26 个独特模型的纳入标准。最常用的结果是 30 天再入院率;只有 1 个模型专门针对可预防的再入院率。有 14 个依赖于回顾性行政数据的模型可能用于对医院比较进行再入院率风险调整;其中 9 个在美国大型人群中进行了测试,区分能力较差(C 统计范围:0.55-0.65)。有 7 个模型可能用于在住院期间早期识别高危患者进行干预(C 统计范围:0.56-0.72),有 5 个模型可在出院时使用(C 统计范围:0.68-0.83)。有 6 项研究在同一人群中比较了不同的模型,其中 2 项研究发现功能和社会变量提高了模型的区分度。尽管大多数模型都纳入了医疗合并症和以前医疗服务使用的变量,但很少检查与整体健康和功能、疾病严重程度或健康的社会决定因素相关的变量。
大多数旨在用于比较或临床目的的当前再入院风险预测模型的性能较差。尽管在某些情况下,此类模型可能证明有用,但随着使用的普及,需要努力提高其性能。